• OPEN AN ACCOUNT
Indian Indices
Sensex
78,799.70 -1,439.15
( -1.79%)
Global Indices
Nasdaq
48,521.56 -404.23
(-0.83%)
Dow Jones
6,836.74 -65.88
(-0.95%)
Hang Seng
56,282.78 -1,774.46
(-3.06%)
Nikkei 225
10,473.49 -306.62
(-2.84%)
Forex
USD-INR
91.48 0.43
(0.47%)
EUR-INR
107.28 -0.27
(-0.25%)
GBP-INR
122.62 -0.09
(-0.07%)
JPY-INR
0.58 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Eiko Lifesciences Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
540204
INE666Q01016
42.7795752
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
23.15
71.74
EPS(TTM)
Face Value()
Div & Yield %
2.16
10
0
 

Edelweiss Financial Services opens Rs 250 cr public issue of NCDs
Dec 05,2025

Edelweiss Financial Services today announced the public issue of 25,00,000 Secured Redeemable Non-Convertible Debentures (NCDs) of the face value of Rs 1,000 each for an amount up to Rs 125 crore (Base Issue Size) with a green shoe option of up to Rs 125 crore, cumulatively aggregating up to Rs 250 crore (Issue Limit).

The Issue has 10 series of NCDs carrying fixed coupons and having a tenure of 24 months, 36 months, 60 months, and 120 months with annual, monthly and cumulative interest options. Effective annual interest yield on the NCDs ranges from 8.85% p.a. to 10.09% p.a.

The Issue is scheduled to open on 05 December 2025 and will close on 18 December 2025.

The NCDs proposed to be issued under the Issue have been rated “Crisil A+/Stable (pronounced as “Crisil A plus rating” with Stable outlook).